AC Immune to Host Webinar Highlighting its Innovative MorphomerTM Technology Platform and Pipeline
Therapeutic and diagnostic Morphomers™ enable AC Immune’s unique precision medicine approach for neurodegenerative diseases
Webinar will take place on Wednesday, March 31, 2021 at 10:00 AM ET
AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it will host a corporate update webinar on Wednesday, March 31st at 10:00 AM ET until 11:30 AM ET.